Fed Circ. agrees Bio-Rad infringed 10x patents

The US Court of Appeals for the Federal Circuit has affirmed a US International Trade Commission (ITC) decision that ruled Bio-Rad Laboratories had infringed three 10x Genomics patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Chinese invisible braces maker hits back at infringement claims

22 August 2025 The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.

Medtech

Invisalign maker sues Chinese rival in Europe, US, and China

21 August 2025 The $4 billion-a-year orthodontics company says its latest lawsuits defend “critical components” of its portfolio as rivals push cheaper alternatives.

Medtech

University files suit over AI ultrasound technology

30 May 2024 University of British Columbia alleges patent infringement by medtech companies | Suit concerns AI-driven ultrasound systems for cardiac imaging.

More features

Insulin pump rivals face off in major trade secrets dispute hearing

Bayer enters COVID-19 vaccine row with three suits against major drugmakers

Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals

Arnold & Porter loses another regulatory partner to growing rival

CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’

Merchant & Gould hires 13 attorneys to open new Boston office

Novo Nordisk secures China win ahead of key patent expiration

Edwards v Meril: Inside the UPC’s landmark medtech showdown

Fed Circ. agrees Bio-Rad infringed 10x patents

More on this story

Editor's picks

Editor's picks

More features